RASA4B Inhibitors

Chemical inhibitors of RASA4B function by disrupting various points of interaction within the cell signaling pathways where RASA4B plays a role, mainly involving its activity as a guanine nucleotide exchange factor (GEF). NSC 23766, for instance, directly targets the interaction between RASA4B and Rac1, a small GTPase. By doing so, it prevents the activation of Rac1 and the subsequent signaling that leads to actin cytoskeleton organization and cell migration. Similarly, EHop-016 acts on the Vav2-Rac1 axis, inhibiting Vav2, which is crucial for RASA4B-associated Rac1 activation. This leads to a halt in cellular processes that are dependent on Rac1 activity. ML141 and CASIN target Cdc42, another GTPase that interacts with RASA4B. By selectively inhibiting Cdc42, these compounds indirectly affect RASA4B's influence over cell signaling related to cytoskeletal dynamics.

Other compounds, such as SecinH3 and ITX3, act by inhibiting proteins that interact with or are parallel to the RASA4B pathway. SecinH3 inhibits cytohesins, which can modulate RASA4B-mediated signaling, whereas ITX3 targets Trio, another GEF that could influence RASA4B activity. AZA1 focuses on LARG, an allosteric inhibitor of a RhoGEF, which could have overlapping roles with RASA4B in regulating the cytoskeleton. By blocking these interactions, the compounds indirectly prevent RASA4B from exerting its effects on cell signaling pathways. Additionally, compounds such as CID2950007, CID44216842, and CID44610309 inhibit various GTPases that would normally be activated by RASA4B, thus affecting the downstream signaling events. Y16 also falls into this category by selectively targeting Rho GTPases, resulting in the indirect inhibition of RASA4B's role in signal transduction. Collectively, these inhibitors act on RASA4B or its associated pathways, thereby modulating its activity and the cellular functions it influences.